There was a bit of a buzz around small cap OKYO Pharma last summer and that excitement could be about to return.
Last week the company appointed Dr Gary S Jacob as its new chief executive. Dr Jacob has worked in the biopharmaceutical industry for 35 years, including a 10-year stint as the boss of Callisto Pharmaceuticals...
OKYO Pharma today effectively confirmed the little snippet in last weekend's Mail on Sunday Stockwatch column, which I occasionally edit when Jamie "Nimmers" Nimmo is away on holiday.
Below is a link to today's announcement from OKYO Pharma, which has appointed Dr Napoleone Ferrara, MD, Professor at the University of California San Diego Medical Center to its scientific advisory board...
Jim Mellon has just dumped his entire stake in tiddler Okyo Pharma, which is developing therapies for inflammatory eye diseases and chronic pain management. Below is a link to the announcement that shows he went down from owning just over 4pc to almost 0.